Both RLYB211 and RLYB212 are designed to rapidly eliminate fetal HPA-1a positive platelets from the circulation of a mother who is HPA-1a negative and prevent the occurrence of maternal ...

Methods: Prospective investigation of fetal and cerebral neonatal circulation was preformed on 36 neonates: I group - 13 infants with physiologic course maternal pregnancy and 20 ones - with ...

In this study, the elimination of transfused platelets serves as a surrogate for assessing the ability of an anti-HPA-1a antibody to drive rapid elimination of HPA-1a positive fetal platelets from an ...